Page last updated: 2024-12-05

pyrrobutamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pyrrobutamine: RN given refers to parent cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5375785
CHEBI ID135334
SCHEMBL ID28347
MeSH IDM0061616

Synonyms (14)

Synonym
pyrrolidine, 1-[4-(4-chlorophenyl)-3-phenyl-2-butenyl]-
pyrrobutamide
pyrrobutamine
91-82-7
CHEBI:135334
1-(4-(4-chlorophenyl)-3-phenylbut-2-enyl)pyrrolidine
SCHEMBL28347
pyrrolidine, 1-[.gamma.-(p-chlorobenzyl)cinnamyl]-
copyronil
1-[(2z)-4-(4-chlorophenyl)-3-phenyl-2-butenyl]pyrrolidine #
WDYYVNNRTDZKAZ-UNOMPAQXSA-N
DB13846
Q63395560
1-(4-(4-chlorophenyl)-3-phenylbut-2-en-1-yl)pyrrolidine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]